PLoS One 2011, 6:e27252 PubMedCentralPubMedCrossRef 21 Burke

PLoS One 2011, 6:e27252.PubMedCentralPubMedCrossRef 21. Burke BI 10773 purchase CW, Mason JN, Surman SL, Jones BG, Dalloneau E, Hurwitz

JL, Russell CJ: Illumination of parainfluenza virus infection and transmission in living animals reveals a tissue-specific dichotomy. PLoS Pathog 2011, 7:e1002134.PubMedCentralPubMedCrossRef 22. Koutsoudakis G, Kaul A, Steinmann E, Kallis S, Lohmann V, Pietschmann T, Bartenschlager R: Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J Virol 2006, 80:5308–5320.PubMedCentralPubMedCrossRef 23. Suree N, Koizumi N, Sahakyan A, Shimizu S, An DS: A novel HIV-1 reporter virus with a membrane-bound Gaussia princeps luciferase. J Virol Methods 2012, 183:49–56.PubMedCrossRef 24. van den Worm SH, Eriksson KK, Zevenhoven JC, Weber F, Zust R, Kuri T, Dijkman R, Chang G, Siddell SG, Snijder EJ, Thiel V, Davidson AD: Reverse genetics of SARS-related coronavirus using vaccinia virus-based recombination. PLoS One 2012, 7:e32857.PubMedCentralPubMedCrossRef 25. Wang X, Deng Y, Li S, Wang G, Qin E, Xu X, Tang

R, Qin C: Biomineralization-based virus shell-engineering: towards neutralization escape and tropism expansion. Adv Healthc Mater 2012, 1:443–449.PubMedCrossRef Inhibitor Library 26. Samsa MM, Mondotte JA, Iglesias NG, Assuncao-Miranda I, Barbosa-Lima G, Da Poian AT, Bozza PT, Gamarnik AV: Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS Pathog 2009, 5:e1000632.PubMedCentralPubMedCrossRef 27. Konishi E, Tabuchi Y, Yamanaka A: A simple assay system for infection-enhancing and -neutralizing antibodies to dengue type 2 virus using layers of semi-adherent K562 cells. J Virol Methods 2010, 163:360–367.PubMedCrossRef 28. Wu SJ, Grouard-Vogel G, Sun W, Mascola JR, Brachtel E, Putvatana R, Louder MK, Filgueira L, Marovich

MA, Wong HK, Blauvelt A, Murphy GS, Robb ML, Innes BL, Birx DL, Hayes CG, Frankel SS: Human skin Langerhans cells are targets of dengue virus infection. Nat Med 2000, 6:816–820.PubMedCrossRef 29. Conceicao TM, Da Poian AT, Sorgine MH: A real-time Calpain PCR procedure for detection of dengue virus serotypes 1, 2, and 3, and their quantitation in clinical and laboratory samples. J Virol Methods 2010, 163:1–9.PubMedCrossRef 30. Halstead SB, O’Rourke EJ, Allison AC: Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection. J Exp Med 1977, 146:218–229.PubMedCentralPubMedCrossRef 31. Yamanaka A, Kosugi S, Konishi E: Infection-enhancing and -neutralizing activities of mouse monoclonal antibodies against dengue type 2 and 4 viruses are controlled by complement levels. J Virol 2008, 82:927–937.PubMedCentralPubMedCrossRef 32.

Comments are closed.